Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient

Guo, Fangjian; Hirth, Jacqueline M.; Berenson, Abbey B.

doi:10.1089/jwh.2017.6424

Cited by 15 publications

(11 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For the current analysis we were also unable to examine screening trends in the context of HPV vaccination, because although the MarketScan data do contain claims for HPV vaccination, a different study design that includes only those continuously enrolled since HPV vaccine was first licensed in the US would be required to ascertain each enrollee's vaccination status with reasonable certainty. However, research to date suggests that vaccinated women are more likely to receive timely screening than unvaccinated women ( Watson et al, 2017 ; Guo et al, 2017 ), so we do not expect that HPV vaccination was a reason for declining screening rates.…”

Section: Strengths and Limitationsmentioning

confidence: 87%

Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003–2014

Watson¹,

Benard²,

Flagg³

2018

Preventive Medicine Reports

View full text Add to dashboard Cite

Improved understanding of the natural history of cervical cancer has led to changes in screening recommendations, including the addition of the human papillomavirus (HPV) testing as an option in routine screening. Most studies of screening trends have used national self-reported survey data. To better understand recent trends in cervical cancer screening, including cytology (Papanicolaou, or Pap, tests) and human papillomavirus co-tests (HPV + Pap test), we used healthcare claims data to examine screening practices and trends. We analyzed screening among commercially-insured females ages 18–65 during 2005–2014 who were continuously enrolled during three or more contiguous calendar years, to identify those who received cervical cancer screening with a Pap test or co-test. We examined screening prevalence by age group and year. During the latter years of our study period, screening prevalence (regardless of screening method) declined significantly for women in all age groups examined. Despite declines in overall screening, the prevalence of co-testing increased in all age groups except those aged 18–20. In 2014, women aged 30–39 had the highest overall screening uptake (77.5%) and the highest use of co-testing (44.4%); this group also had the lowest overall declines in screening over the time period (−4.5%). These screening measures from healthcare claims were lower than self-reported screening from national surveys of the general population. More research to explore the reasons for these differences is needed to ensure that women are receiving appropriate screening, and to better understand why screening prevalence is declining among this population of commercially insured women.

show abstract

Section: Strengths and Limitationsmentioning

confidence: 87%

Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003–2014

Watson¹,

Benard²,

Flagg³

2018

Preventive Medicine Reports

View full text Add to dashboard Cite

show abstract

“…Further, rural residents are more likely to state cost as a factor in not receiving screening, have less access to specialty cancer care, not receive physician recommendations for screening, and experience higher rates of screening‐preventable cancers and higher cancer mortality . As primary care providers have a substantial influence on their patients’ uptake of screening, a strategy may be to encourage primary care physicians to consistently recommend screening . However, there is insufficient evidence for recommending regular oral cancer or other site screenings …”

Section: Discussionmentioning

confidence: 99%

Rural‐Urban Differences in Human Papillomavirus‐associated Cancer Trends and Rates

Zahnd

Rodriguez

Jenkins

2018

The Journal of Rural Health

View full text Add to dashboard Cite

show abstract

“…To date, it has not been studied whether HPV vaccination status has an impact on subsequent cancer screening participation. A previous study implied that the screening rate was relatively higher in HPV-vaccinated women than in unvaccinated ones [ 14 ]; however, the unvaccinated group in the study was significantly older than the vaccinated group ( p < 0.001), and therefore, it seemed that an age distribution difference may have affected the result. Another report was our own interim analysis [ 15 ].…”

Section: Introductionmentioning

confidence: 79%

Disparity of Cervical Cancer Risk in Young Japanese Women: Bipolarized Status of HPV Vaccination and Cancer Screening

et al. 2021

View full text Add to dashboard Cite

Women born between 1994 and 1999 achieved high vaccination rates for human papillomavirus (HPV); they are now reaching the age of cervical cancer screening programs in Japan. In this study, we aimed to investigate the health awareness of HPV-vaccinated and unvaccinated women and to create tailored leaflets recommending cervical cancer screening for each. Surveys on the cancer screening rates for HPV-vaccinated and unvaccinated women aged 20 and 21 have demonstrated that the rate was significantly higher (p < 0.01) in vaccinated (6.2%) than in unvaccinated women (3.1%). Next, interviews and Internet questionnaires clarified that there was a trend that vaccinated women have a better health consciousness than the unvaccinated ones, and that in unvaccinated women, their willingness to receive cervical cancer screening was significantly enhanced by the fear of developing cancer. Finally, in a prospective study, the increase in the screening rate for both vaccinated and unvaccinated groups after they read tailored leaflets, from 6.4% to 7.4% and from 3.9% to 5.1%, respectively, was not statistically significant compared to the groups provided with a standard reminder letter. Cervical cancer control measures might be enhanced by recommending cervical cancer screening in ways better tailored to HPV vaccination status.

show abstract

Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient

Cited by 15 publications

References 40 publications

Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003–2014

Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003–2014

Rural‐Urban Differences in Human Papillomavirus‐associated Cancer Trends and Rates

Disparity of Cervical Cancer Risk in Young Japanese Women: Bipolarized Status of HPV Vaccination and Cancer Screening

Contact Info

Product

Resources

About